NCT07497334 · RECRUITING

A Novel Multi-Modal Approach to Promote Functional Outcomes in Cognitively Frail Older Adults

This trial is testing whether a combination of two types of brain stimulation (theta burst stimulation, delivered using a magnetic coil placed on the scalp) paired with aerobic exercise improves thinking and movement in older adults who have both mild cognitive impairment and physical frailty. It is a Phase NA trial, meaning it is a feasibility or mechanistic study rather than a late-stage efficacy test — researchers are still working out how this combination affects the brain.

You may qualify if

  • be between 60 and 90 years old;
  • scored \< 9/12 on the SPPB;
  • scored >18/30 on the MoCA;
  • scored >9/42 on the PFFS;
  • lived in the community;
  • be able to ambulate up to four meters with or without assistive devices;
  • be able to provide written informed consent on their own behalf;
  • can understand verbal and written Cantonese and/or English.

You're excluded if

  • have magnetic resonance imaging (MRI) contraindications;
  • have aerobic exercise contraindications;
  • have transcranial magnetic stimulation contraindications;
  • be diagnosed with neurodegenerative conditions (i.e., dementia, Parkinson's, Alzheimer's disease, Amyotrophic lateral sclerosis, and stroke);
  • live in a nursing home or other care facilities/institutions;
  • bed taking fixed dose of medication or had been taking medications known to potentially affect cognitive and physical function (e.g., psychotropic medications), as identified through a review of their medication lists recorded in the health software. Medications were categorized by properties (e.g., antipsychotics, antidepressants, etc.) to inform eligibility decisions.
  • have a history indicative of carotid sinus sensitivity (i.e., falls due to loss of consciousness);
  • cancer and undergo radiation therapy.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-03-27

View full record on ClinicalTrials.gov

All APOE4 clinical trials